This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanchez, A. E.
Right arrow Articles by Rocha-Zavaleta, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanchez, A. E.
Right arrow Articles by Rocha-Zavaleta, L.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, July 2004, p. 711-719, Vol. 11, No. 4
1071-412X/04/$08.00+0     DOI: 10.1128/CDLI.11.4.711-719.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Cholera Toxin B-Subunit Gene Enhances Mucosal Immunoglobulin A, Th1-Type, and CD8+ Cytotoxic Responses When Coadministered Intradermally with a DNA Vaccine

Alba E. Sanchez,1 Guillermo Aquino,1 Pedro Ostoa-Saloma,2 Juan P. Laclette,2 and Leticia Rocha-Zavaleta1*

Department of Molecular Biology and Biotechnology,1 Department of Immunology, Institute of Biomedical Research, National University of Mexico, Mexico, D.F. 04510, Mexico2

Received 3 November 2003/ Returned for modification 2 February 2004/ Accepted 18 March 2004

A plasmid vector encoding the cholera toxin B subunit (pCtB) was evaluated as an intradermal genetic adjuvant for a model DNA vaccine expressing the human papillomavirus type 16 L1 capsid gene (p16L1) in mice. p16L1 was coadministered with plasmid pCtB or commercial polypeptide CtB as a positive control. Coadministration of pCtB induced a significant increment of specific anti-L1 immunoglobulin A (IgA) antibodies in cervical secretions (P < 0.05) and fecal extracts (P < 0.005). Additionally, coadministration of pCtB enhanced the production of interleukin-2 and gamma interferon by spleen cells but did not affect the production of interleukin-4, suggesting a Th1-type helper response. Furthermore, improved CD8+ T-cell-mediated cytotoxic activity was observed in mice vaccinated with the DNA vaccine with pCtB as an adjuvant. This adjuvant effect was comparable to that induced by the CtB polypeptide. These results indicate that intradermal coadministration of pCtB is an adequate means to enhance the mucosa-, Th1-, and CD8+-mediated cytotoxic responses induced by a DNA vaccine.

* Corresponding author. Mailing address: Instituto de Investigaciones Biomédicas, Depto. Biología Molecular y Biotecnología, UNAM, Circuito Escolar s/n, Ciudad Universitaria, Apdo. Postal 70228, México D.F. CP 04510, Mexico. Phone: (52 55) 56 22 38 76. Fax: (52 55) 56 22 38 55. E-mail: lrochaz{at}servidor.unam.mx.

Clinical and Diagnostic Laboratory Immunology, July 2004, p. 711-719, Vol. 11, No. 4
1071-412X/04/$08.00+0     DOI: 10.1128/CDLI.11.4.711-719.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»